204 related articles for article (PubMed ID: 16119006)
21. The synthesis of N-acetyl-4-S-cysteaminyl [U-14C]phenol as a basis for the development of an antimelanoma and melanoma-radioimaging agent.
Iwashina T; Jimbow K; Wiebe LI
Appl Radiat Isot; 1994 Jun; 45(6):703-5. PubMed ID: 8038763
[TBL] [Abstract][Full Text] [Related]
22. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma].
Jimbow K; Miura S; Ito Y; Kasuga T; Ito S
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
24. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Miura T; Jimbow K; Ito S
Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
Kumar V; Mudgal MM; Rani N; Jha A; Jaggi M; Singh AT; Sanna VK; Singh P; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):763-70. PubMed ID: 18720190
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of 6-(3-hydroxyphenyl)-2-naphthol on tyrosinase activity and melanin synthesis.
Chung SW; Ha YM; Kim YJ; Song S; Lee H; Suh H; Chung HY
Arch Pharm Res; 2009 Feb; 32(2):289-94. PubMed ID: 19280161
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of glycoside inhibitors of glioma and melanoma growth.
García-Alvarez I; Corrales G; Doncel-Pérez E; Muñoz A; Nieto-Sampedro M; Fernández-Mayoralas A
J Med Chem; 2007 Jan; 50(2):364-73. PubMed ID: 17228879
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiproliferative activity of two new tiazofurin analogues with 2'-amido functionalities.
Popsavin M; Torović L; Svircev M; Kojić V; Bogdanović G; Popsavin V
Bioorg Med Chem Lett; 2006 May; 16(10):2773-6. PubMed ID: 16495053
[TBL] [Abstract][Full Text] [Related]
31. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
Ito Y; Jimbow K
Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
[TBL] [Abstract][Full Text] [Related]
32. Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis.
Minamitsuji Y; Toyofuku K; Sugiyama S; Yamada K; Jimbow K
J Investig Dermatol Symp Proc; 1999 Sep; 4(2):130-6. PubMed ID: 10536987
[TBL] [Abstract][Full Text] [Related]
33. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
[TBL] [Abstract][Full Text] [Related]
34. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
[TBL] [Abstract][Full Text] [Related]
35. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of cryptolepine analogues as potential bioreducible anticancer agents.
Seville S; Phillips RM; Shnyder SD; Wright CW
Bioorg Med Chem; 2007 Oct; 15(19):6353-60. PubMed ID: 17643990
[TBL] [Abstract][Full Text] [Related]
37. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.
Ito S; Nishigaki A; Ishii-Osai Y; Ojika M; Wakamatsu K; Yamashita T; Tamura Y; Ito A; Honda H; Nakayama E; Jimbow K
Biochem Pharmacol; 2012 Sep; 84(5):646-53. PubMed ID: 22728921
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma.
Li W; Wang Z; Gududuru V; Zbytek B; Slominski AT; Dalton JT; Miller DD
Anticancer Res; 2007; 27(2):883-8. PubMed ID: 17465215
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of C4-fluorinated solamins and their growth inhibitory activity against human cancer cell lines.
Kojima N; Hayashi H; Suzuki S; Tominaga H; Maezaki N; Tanaka T; Yamori T
Bioorg Med Chem Lett; 2008 Dec; 18(24):6451-3. PubMed ID: 18993063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]